# Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

> **NCT07053917** · PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 20 (estimated)

## Conditions studied

- Stroke
- Chronic Stroke
- Intracerebral Haemorrhage
- Intracerebral Haemorrhage (ICH)
- Intracerebral Hemorrhage Basal Ganglia
- Ischemic Stroke
- Ischemic Stroke and Hemorrhagic Stroke
- Hemiparesis After Stroke
- Hemiplegia Following Ischemic Stroke
- Hemiplegia and Hemiparesis
- Hemiplegia and/or Hemiparesis Following Stroke
- Middle Cerebral Artery Stroke

## Interventions

- **DRUG:** Psilocybin (Usona Institute)

## Key facts

- **NCT ID:** NCT07053917
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2027-02
- **Final completion:** 2027-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053917, "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07053917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*